MedPath

Effects of Non-calorie Sweeteners, Mono- and Disaccharides on Intestinal Barrier Function

Not Applicable
Completed
Conditions
Dietary Habits
Endotoxemia
Interventions
Other: Dietary Intervention 2
Other: Dietary Intervention 4
Other: Dietary intervention 1
Other: Dietary Intervention 3
Registration Number
NCT04788680
Lead Sponsor
University of Vienna
Brief Summary

The aim of the present study is to determine the effect of non-nutritive sweeteners on intestinal barrier function and inflammatory markers in healthy subjects in comparison to mono- and disaccharides.

Detailed Description

In the intervention study normal weight participants will receive beverages sweetened with non-nutritive sweeteners, mono- and disaccharides for a defined number of days. Before and after intervention parameters of intestinal barrier function will be assessed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • No known history of metabolic diseases/disorders
  • BMI <25 kg/m2
Exclusion Criteria
  • Food allergies or intolerances (esp. fructose intolerance and malabsorption)
  • Chronic disease of the gastrointestinal tract
  • Renal insufficiency
  • Taking drugs affecting lipid or glucose metabolism

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Experimental: Beverage 2Dietary Intervention 2Participants receive a beverage with a defined amount of non-nutritive sweetener.
Experimental: Beverage 4Dietary Intervention 4Participants receive a beverage with a defined amount of disaccharide.
Experimental: Beverage 1Dietary intervention 1Participants receive a beverage with a defined amount of non-nutritive sweetener.
Experimental: Beverage 3Dietary Intervention 3Participants receive a beverage with a defined amount of monosaccharide.
Primary Outcome Measures
NameTimeMethod
Changes in inflammatory markers.1 week

Changes in IL-6 plasma levels (ng/ml).

Changes in parameters of intestinal barrier function.1 week

Changes in plasma endotoxin levels.

Secondary Outcome Measures
NameTimeMethod
Changes in markers for glucose metabolism.1 week

Changes in fasting insulin levels (mU/l).

Changes in blood lipid levels.1 week

Changes in triglyceride levels.

Changes in blood pressure.1 week

Changes in systolic and diastolic blood pressure

Trial Locations

Locations (1)

University of Vienna

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath